| (Values in U.S. Thousands) | Jun, 2024 | Jun, 2023 | Jun, 2022 | Jun, 2021 | Jun, 2020 |
| Sales | 0 | 0 | 42,250 | 36,230 | 42,115 |
| Sales Growth | unch | unch | +16.62% | -13.97% | -41.35% |
| Net Income | -801 | -16,829 | 665 | -10,112 | -7,566 |
| Net Income Growth | +95.24% | -2,630.68% | +106.58% | -33.65% | -3,119.57% |
Health and Plant Protein Group Ltd (HPP.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Health and Plant Protein Group Ltd is an Australia-based company. The group had no main business undertaking or material operations that generate cash surpluses for the shareholders, as it sought to finalise the transactions and cashflows associated with the sale of HPP America, Inc., the USA-based holding company of MacFarms, LLC (the 'HPP America Sale') in April 2023. Following this sale, the group had no important business operations generating cash surpluses and focused on finalizing related transactions and cashflows. The company is currently in a transitional phase, with no active revenue-generating businesses, and intends to determine future business plans and potential capital returns to shareholders after concluding the sale-related activities.
Fiscal Year End Date: 06/30